0
Article |

Limitations of Theophylline in the Treatment of Apnea of Prematurity FREE

Maureen E. Sims, MD; Gloria Yau, MD; Savitri Rambhatla, MD; Luis Cabal, MD; Paul Y. K Wu, MD
[+] Author Affiliations

Reprints not available.


Am J Dis Child. 1985;139(6):567-570. doi:10.1001/archpedi.1985.02140080037028.
Text Size: A A A
Published online

• Theophylline is commonly used to treat apnea of prematurity. To determine the effectiveness of theophylline with respect to gestational and postnatal age, we conducted a controlled study in 43 premature infants with idiopathic apnea. Three of the 21 treated and eight of the 22 control infants developed respiratory failure. Eight of the 11 infants with respiratory failure had gestational ages of less than 31 weeks and had more than four apneic episodes during the first day of life. In the treated infants without respiratory failure, the number of apneic episodes by 24-hour intervals declined six days earlier than in the control infants. Apnea disappeared, however, at a similar time in both groups. Three treated infants and three control infants had apneic episodes persisting beyond the neonatal period. Patients treated with theophylline did not develop respiratory failure as often as control infants did. However, despite a reduction of apneic episodes, theophylline did not shorten the course of apnea of prematurity.

(AJDC 1985;139:567-570)

REFERENCES

Peabody JL, Neese AL, Philip AGS, et al:  Transcutaneous oxygen monitoring in aminophylline-treated apneic infants . Pediatrics 1978;; 62:698-701.
Hiatt IM, Hegyi T, Indyk L, et al:  Continuous monitoring of PO2 during apnea of prematurity . J Pediatr 1981;;98:288-291.
Daily WJR, Klaus M, Meyer HBP:  Apnea in premature infants: Monitoring incidence, heart rate changes, and an effect of environmental temperature . Pediatrics 1969;;43:510-517.
Rigatto H:  Apnea and periodic breathing . Semin Perinatol 1977;;1:375-381.
Cooke RWI, Rolfe P, Howat P:  Apparent cerebral blood flow in newborns with respiratory disease . Dev Med Child Neurol 1979;;21:154-160.
Kuzemko JA, Paala J:  Apneoic attacks in the newborn treated with aminophylline . Arch Dis Child 1973;;48:404-406.
Shannon DC, Gotay F, Stein IM, et al:  Prevention of apnea and bradycardia in low-birthweight infants . Pediatrics 1975;;55:589-594.
Uauy R, Shapiro DL, Smith B, et al:  Treatment of severe apnea in prematures with orally administered theophylline . Pediatrics 1975;;55: 595-598.
Bednarek FJ, Roloff DW:  Treatment of apnea of prematurity with aminophylline . Pediatrics 1976;;58:335-339.
Rigatto H:  Apnea . Pediatr Clin North Am 1982;;29:1105-1106.
Kattwinkel J:  Neonatal apnea: Pathogenesis and therapy . J Pediatr 1977;;90:342-347.
Schulte FJ:  Apnea . Clin Perinatol 1977;;4: 65-76.
Gerhardt T, Bancalari E:  Apnea of prematurity: I. Lung function and regulation of breathing . Pediatrics 1984;;74:58-62.
Gerhardt T, Bancalari E:  Chestwall compliance in full-term and premature infants . Acta Paediatr Scand 1980;;69:359-364.
Muller N, Volgyesi G, Bryan MH, et al:  The consequences of diaphragmatic muscle fatigue in the newborn infant . J Pediatr 1979;;95: 793-797.
Roberts JL, Mathew OP, Thach BT:  The efficacy of theophylline in premature infants with mixed and obstructive apnea and apnea associated with pulmonary and neurologic disease . J Pediatr 1982;;100:968-970.
Aranda JV, Grondin D, Sasyniuk BI:  Pharmacologic considerations in the therapy of neonatal apnea . Pediatr Clin North Am 1981;;28: 113-133.

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Peabody JL, Neese AL, Philip AGS, et al:  Transcutaneous oxygen monitoring in aminophylline-treated apneic infants . Pediatrics 1978;; 62:698-701.
Hiatt IM, Hegyi T, Indyk L, et al:  Continuous monitoring of PO2 during apnea of prematurity . J Pediatr 1981;;98:288-291.
Daily WJR, Klaus M, Meyer HBP:  Apnea in premature infants: Monitoring incidence, heart rate changes, and an effect of environmental temperature . Pediatrics 1969;;43:510-517.
Rigatto H:  Apnea and periodic breathing . Semin Perinatol 1977;;1:375-381.
Cooke RWI, Rolfe P, Howat P:  Apparent cerebral blood flow in newborns with respiratory disease . Dev Med Child Neurol 1979;;21:154-160.
Kuzemko JA, Paala J:  Apneoic attacks in the newborn treated with aminophylline . Arch Dis Child 1973;;48:404-406.
Shannon DC, Gotay F, Stein IM, et al:  Prevention of apnea and bradycardia in low-birthweight infants . Pediatrics 1975;;55:589-594.
Uauy R, Shapiro DL, Smith B, et al:  Treatment of severe apnea in prematures with orally administered theophylline . Pediatrics 1975;;55: 595-598.
Bednarek FJ, Roloff DW:  Treatment of apnea of prematurity with aminophylline . Pediatrics 1976;;58:335-339.
Rigatto H:  Apnea . Pediatr Clin North Am 1982;;29:1105-1106.
Kattwinkel J:  Neonatal apnea: Pathogenesis and therapy . J Pediatr 1977;;90:342-347.
Schulte FJ:  Apnea . Clin Perinatol 1977;;4: 65-76.
Gerhardt T, Bancalari E:  Apnea of prematurity: I. Lung function and regulation of breathing . Pediatrics 1984;;74:58-62.
Gerhardt T, Bancalari E:  Chestwall compliance in full-term and premature infants . Acta Paediatr Scand 1980;;69:359-364.
Muller N, Volgyesi G, Bryan MH, et al:  The consequences of diaphragmatic muscle fatigue in the newborn infant . J Pediatr 1979;;95: 793-797.
Roberts JL, Mathew OP, Thach BT:  The efficacy of theophylline in premature infants with mixed and obstructive apnea and apnea associated with pulmonary and neurologic disease . J Pediatr 1982;;100:968-970.
Aranda JV, Grondin D, Sasyniuk BI:  Pharmacologic considerations in the therapy of neonatal apnea . Pediatr Clin North Am 1981;;28: 113-133.

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.